![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Cazzola M.
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.9, Iss.2, 2000-02, pp. : 237-246
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Cazzola M. Matera M.G. Donner C.F.
Clinical Drug Investigation, Vol. 16, Iss. 4, 1998-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Expert Opinion on Emerging Drugs, Vol. 12, Iss. 4, 2007-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Novel Oral Suspensions: A Review
Current Drug Delivery, Vol. 11, Iss. 3, 2014-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cephalosporins in clinical development
Expert Opinion on Investigational Drugs, Vol. 13, Iss. 8, 2004-08 ,pp. :